Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma Meeting Abstract
| Authors: | Hakimi, A. A.; Ostrovnaya, I.; Jacobsen, A.; Coleman, J. A.; Russo, P.; Mano, R.; Sankin, A.; Motzer, R. J.; Purdue, M.; Pomerantz, M.; Freedman, M. L.; Choueiri, T. K.; Hsieh, J.; Klein, R. J. |
| Abstract Title: | Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma |
| Meeting Title: | 2014 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2014 Jan 30-Feb 1 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-02-01 |
| Language: | English |
| ACCESSION: | WOS:000335318100395 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.4_suppl.395 |
| Notes: | Meeting Abstract: 395 -- Genitourinary Cancers Symposium -- JAN 30-FEB 01, 2014 -- San Francisco, CA -- S -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work